First-pass extracted concept

immunotherapy for neurodegenerative diseases

Candidate: concept label1 source documents4 linked claims

Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Aliases

immunotherapies for neurodegenerative diseases

Evidence Snippets

Emerging evidence supports a potential role for immunotherapy in the management of disease progression.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1review2021Frontiers in NeurologyDOI PubMed

1 evidence snippet 4 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1mechanistic rationalesupports2021Source 1DOI PubMed

The immune system or its derivative components may be harnessed to fight misfolded and aggregated proteins that accumulate in several neurodegenerative diseases.

Claim 2review scopesupports2021Source 1DOI PubMed

The review focuses on prominent immunotherapeutic strategies to fight neuroinflammation-induced neurodegeneration, with emphasis on vaccination therapy.

Claim 3review summarysupports2021Source 1DOI PubMed

Current treatments for neurodegenerative diseases are mostly symptomatic and generally do not affect the underlying cause of disease.

Claim 4review summarysupports2021Source 1DOI PubMed

Emerging evidence supports a potential role for immunotherapy in managing neurodegenerative disease progression.